Marinomed wins STEP award in "Market/Customer" category and special award for strategic partnerships
Marinomed impressed the jury in the "Market/ Customer" category, as its anti-viral nasal spray features significant and direct benefits for the patient, the end consumer. In addition, the strategic cooperation agreement out-licensing the nasal spray to Boehringer Ingelheim for the European, Latin American, Russian & CIS, Asian and Australian markets clearly shows the product’s high market potential.
Dr. Andreas Grassauer, CEO and co-founder of Marinomed, commented: “We are delighted that Marinomed has been awarded with these two prizes. They not only confirm our successful business strategy, but also the value of our innovative product.”
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.